Skip to main content
. 2020 May 29;15(5):e0234073. doi: 10.1371/journal.pone.0234073

Fig 5. Incidence of malocclusion in vehicle and TNAP treated FGFR2C342Y/+ mice.

Fig 5

Percentage of FGFR2C342Y/+ (Cz) mice with a class III malocclusion are shown. Treatment with TNAP lentivirus significantly diminished malocclusion in C57BL/6 FGFR2C342Y/+ (Cz) but not BALB/c FGFR2C342Y/+ (Cz) mice. *p<0.03.